Chrissy Buteas, the new CEO of the HealthCare Institute of New Jersey (HINJ), expressed her enthusiasm for her role, emphasizing the importance of the industry. "Iconic industry that saves lives," she stated.
Buteas elaborated on the significance of New Jersey-based companies in providing life-saving treatments over the past century. "Our residents are benefiting from the life-saving treatments our companies have been providing for more than 100 years," she said. "Our brothers, our sisters, our parents, our grandparents — it’s hard-pressed to find somebody who is not receiving the benefit from a New Jersey-based company right now."
Buteas also highlighted that less than 10% of healthcare spending goes towards prescription drugs, a figure that has remained consistent since the 1960s.
